Linagliptin 5mg and (SR) 500mg Metformin Hydrochloride '''

Linagliptin 5mg and Metformin Hydrochloride (SR) 500mg
LINALIGLIP M 5/500  
Linagliptin is an oral antidiabetic medication that belongs to a class of drugs called dipeptidyl peptidase-4 (DPP-4) inhibitors.
Its primary function is to lower blood sugar levels by inhibiting the action of the DPP-4 enzyme. This enzyme breaks down incretins, which are hormones that stimulate the release of insulin from the pancreas and reduce the production of glucose by the liver.
By inhibiting DPP-4, linagliptin prolongs the action of incretins, which in turn increases insulin secretion and reduces glucagon release, leading to better blood sugar control.
Metformin is another oral antidiabetic drug that is part of the biguanide class.
It primarily works by reducing the amount of glucose produced by the liver and improving the body's sensitivity to insulin. This results in lower blood sugar levels and better glucose utilization by the cells.
Metformin may also have some additional benefits, such as promoting weight loss and reducing the risk of heart disease in people with type 2 diabetes.
Steris Healthcare Pvt. Ltd. is a Leading Pharmaceutical Company in India. Established in the year of May 2018. We have 750+ Products & 16+ Super Specialty Segments. Every week we have a new product in our portfolio. In Last 4 years we are dealing in Chronic Therapy and in 4 years we grow by 200% Annually, because we deal in high quality medicine. Steris medicine manufactures at WHO-GMP Approved Plants & We have Legal manufacturing contracts with all leading manufacturers of India. Today we have 1000+ Business Franchise Partners in PAN India. Steris's medicine supply in India's Top or Reputed Hospitals, Pharmacy, Government use or Railway use. Grow with a similar pace with the STERIS. Be first to launch like us.
For further information please contact:
contact@sterispharma.com
order now:
https://www.sterisonline.com/product/linaliglip-m-5-500-134301